CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity

Affiliations

• ¹ Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. [email protected].
• ² Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
• ³ Pompeu Fabra University, Barcelona, Spain.
• ⁴ Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.
• ⁵ Hematology Department, Hospital Clínico de Barcelona, Barcelona, Spain.
• ⁶ Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
• ⁷ Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. [email protected].
• ⁸ Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. [email protected].
• ⁹ Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain. [email protected].